Ministry of Defence
Ministry of Defence received $4.4M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 49.8% from $2.9M the year before, and $12.3M since FY2022. Its largest customer is the Department of Defense.
See 2 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- U6LDUQKZ2CS8
- CAGE code
- KB887
- Doing business as
- D S T L
- Headquarters
- Salisbury, GBR
- Business size
- Other Than Small Business
- Parent company
- Department of Health (UEI JTWFXECABGV5)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Defense | $4.4M | $12.4M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AC32 | National Defense R&D services; Defense-Related activities; Applied Research | $11.1M |
| AD93 | R&D- Defense other: Other (Advanced Development) | $885K |
| AC31 | National Defense R&D services; Defense-Related activities; Basic Research | $870K |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| HDTRA124C0008 | Department of Defense GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $5.6M | Jun 9, 2027 |
| HDTRA122C0032 | Department of Defense NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $5.5M | Sep 27, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| HDTRA124C0008 | Department of Defense GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $535K | Jun 6, 2024 |
| HDTRA122C0035 | Department of Defense FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $120K | Sep 29, 2022 |
| HDTRA122C0032 | Department of Defense NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $200K | Sep 28, 2022 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.